CM
TWST icon

Caption Management’s Twist Bioscience TWST Stock Holding History

Caption Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8,100
Closed -$193K – 1568
2022
Q4 		$193K Buy
+8,100
New +$235K ﹤0.01% 1066

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Caption Management's TWST Position: Q1 2023 in Review

Caption Management sold out of Twist Bioscience (TWST) in Q1 2023, closing a stake of 8,100 shares — an estimated $193K sold.

Caption Management first reported a position in TWST in Q4 2022 and held it in 1 quarter. The position peaked at $193K in Q4 2022. 201 funds tracked by Wall St. Rank hold TWST as of Q1 2023.

  • Caption Management reported no remaining Twist Bioscience position as of Q1 2023 after selling out during the quarter.
  • Caption Management sold 8,100 Twist Bioscience shares in Q1 2023, an estimated $193K.
  • Caption Management first reported a position in Twist Bioscience in Q4 2022 and held it in 1 quarter.
  • Caption Management's Twist Bioscience position peaked at $193K in Q4 2022.
  • 201 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2023.

Based on Caption Management's 13F filing for Q1 2023, filed 15 May 2023.